Advisors Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.56M | Buy |
106,094
+16,651
| +19% | +$881K | 0.08% | 321 |
|
|
2026
Q1 | $4.94M | Buy |
89,443
+18,014
| +25% | +$976K | 0.08% | 333 |
|
|
2025
Q4 | $3.5M | Sell |
71,429
-8,533
| -11% | -$398K | 0.06% | 419 |
|
|
2025
Q3 | $3.45M | Sell |
79,962
-18,997
| -19% | -$742K | 0.06% | 428 |
|
|
2025
Q2 | $3.8M | Sell |
98,959
-24,824
| -20% | -$949K | 0.07% | 392 |
|
|
2025
Q1 | $4.8M | Sell |
123,783
-3,868
| -3% | -$142K | 0.09% | 289 |
|
|
2024
Q4 | $4.32M | Sell |
127,651
-14,697
| -10% | -$529K | 0.08% | 327 |
|
|
2024
Q3 | $5.82M | Buy |
142,348
+14,565
| +11% | +$596K | 0.11% | 243 |
|
|
2024
Q2 | $4.92M | Buy |
127,783
+8,047
| +7% | +$338K | 0.1% | 264 |
|
|
2024
Q1 | $5.13M | Buy |
119,736
+6,559
| +6% | +$270K | 0.1% | 261 |
|
|
2023
Q4 | $4.19M | Sell |
113,177
-629
| -0.6% | -$22.6K | 0.09% | 293 |
|
|
2023
Q3 | $4.13M | Buy |
113,806
+2,847
| +3% | +$101K | 0.09% | 287 |
|
|
2023
Q2 | $3.95M | Sell |
110,959
-1,845
| -2% | -$66.2K | 0.08% | 315 |
|
|
2023
Q1 | $4.01M | Sell |
112,804
-3,148
| -3% | -$110K | 0.08% | 308 |
|
|
2022
Q4 | $4.07M | Buy |
115,952
+11,385
| +11% | +$379K | 0.08% | 284 |
|
|
2022
Q3 | $3.08M | Sell |
104,567
-301
| -0.3% | -$11.4K | 0.06% | 349 |
|
|
2022
Q2 | $5.71M | Buy |
104,868
+9,946
| +10% | +$549K | 0.11% | 206 |
|
|
2022
Q1 | $5.17M | Buy |
94,922
+14,647
| +18% | +$796K | 0.08% | 265 |
|
|
2021
Q4 | $4.42M | Buy |
80,275
+8,189
| +11% | +$426K | 0.06% | 338 |
|
|
2021
Q3 | $3.44M | Buy |
72,086
+7,616
| +12% | +$383K | 0.05% | 397 |
|
|
2021
Q2 | $3.21M | Sell |
64,470
-4,570
| -7% | -$220K | 0.05% | 425 |
|
|
2021
Q1 | $3.08M | Sell |
69,040
-2,367
| -3% | -$107K | 0.05% | 422 |
|
|
2020
Q4 | $3.29M | Sell |
71,407
-9,567
| -12% | -$439K | 0.05% | 360 |
|
|
2020
Q3 | $3.81M | Sell |
80,974
-4,652
| -5% | -$233K | 0.07% | 267 |
|
|
2020
Q2 | $4.37M | Sell |
85,626
-14,138
| -14% | -$725K | 0.09% | 234 |
|
|
2020
Q1 | $4.73M | Sell |
99,764
-4,279
| -4% | -$228K | 0.11% | 177 |
|
|
2019
Q4 | $6.11M | Sell |
104,043
-6,200
| -6% | -$345K | 0.11% | 223 |
|
|
2019
Q3 | $5.88M | Sell |
110,243
-9,729
| -8% | -$500K | 0.11% | 228 |
|
|
2019
Q2 | $6M | Sell |
119,972
-12,804
| -10% | -$642K | 0.11% | 222 |
|
|
2019
Q1 | $6.94M | Sell |
132,776
-2,460
| -2% | -$123K | 0.13% | 192 |
|
|
2018
Q4 | $6.46M | Sell |
135,236
-10,438
| -7% | -$514K | 0.13% | 186 |
|
|
2018
Q3 | $7.32M | Sell |
145,674
-1,102
| -0.8% | -$56K | 0.12% | 211 |
|
|
2018
Q2 | $7.4M | Buy |
146,776
+5,343
| +4% | +$269K | 0.13% | 205 |
|
|
2018
Q1 | $6.42M | Buy |
141,433
+3,992
| +3% | +$186K | 0.11% | 239 |
|
|
2017
Q4 | $6.09M | Buy |
137,441
+287
| +0.2% | +$13.3K | 0.1% | 261 |
|
|
2017
Q3 | $6.96M | Buy |
137,154
+10,758
| +9% | +$546K | 0.12% | 234 |
|
|
2017
Q2 | $6.81M | Buy |
126,396
+12,706
| +11% | +$677K | 0.11% | 250 |
|
|
2017
Q1 | $5.99M | Sell |
113,690
-25,605
| -18% | -$1.3M | 0.1% | 276 |
|
|
2016
Q4 | $6.71M | Sell |
139,295
-5,083
| -4% | -$251K | 0.11% | 266 |
|
|
2016
Q3 | $7.78M | Sell |
144,378
-17,926
| -11% | -$983K | 0.13% | 237 |
|
|
2016
Q2 | $8.79M | Sell |
162,304
-9,526
| -6% | -$502K | 0.14% | 214 |
|
|
2016
Q1 | $8.71M | Sell |
171,830
-29,188
| -15% | -$1.45M | 0.14% | 202 |
|
|
2015
Q4 | $10.1M | Sell |
201,018
-7,754
| -4% | -$395K | 0.16% | 177 |
|
|
2015
Q3 | $10M | Sell |
208,772
-15,607
| -7% | -$812K | 0.16% | 170 |
|
|
2015
Q2 | $11.7M | Buy |
224,379
+8,348
| +4% | +$470K | 0.16% | 171 |
|
|
2015
Q1 | $12.5M | Buy |
216,031
+3,630
| +2% | +$208K | 0.17% | 165 |
|
|
2014
Q4 | $11.3M | Sell |
212,401
-3,857
| -2% | -$216K | 0.15% | 180 |
|
|
2014
Q3 | $12.4M | Buy |
216,258
+10,342
| +5% | +$634K | 0.17% | 165 |
|
|
2014
Q2 | $13.8M | Buy |
205,916
+26,659
| +15% | +$1.8M | 0.19% | 144 |
|
|
2014
Q1 | $12M | Buy |
179,257
+15,466
| +9% | +$1.05M | 0.18% | 151 |
|
|
2013
Q4 | $10.9M | Buy |
163,791
+22,022
| +16% | +$1.43M | 0.18% | 160 |
|
|
2013
Q3 | $8.89M | Buy |
141,769
+13,938
| +11% | +$897K | 0.16% | 187 |
|
|
2013
Q2 | $7.99M | Buy |
+127,831
| New | +$8.11M | 0.15% | 201 |
|
Other funds holding GSK
JEST
Advisors Asset Management's GSK Position: Q2 2026 in Review
Advisors Asset Management increased its GSK (GSK) stake by 19% in Q2 2026, buying an estimated $881K and bringing the position to 106,094 shares worth $5.56M. The position accounts for 0.08% of the portfolio, ranked #321.
Advisors Asset Management first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.8M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Advisors Asset Management held 106,094 shares of GSK worth $5.56M as of Q2 2026.
- Advisors Asset Management bought 16,651 GSK shares in Q2 2026, an estimated $881K.
- GSK made up 0.08% of Advisors Asset Management's portfolio in Q2 2026, its #321 holding.
- Advisors Asset Management first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Advisors Asset Management's GSK position peaked at $13.8M in Q2 2014.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.